Join
Live feed
·
INSIDERFilingvia Quantisnow
Nabriva Therapeutics plc logo

SEC Form 4: Burgess Daniel D sold $2,156 worth of Ordinary Shares (11,341 units at $0.19), decreasing direct ownership by 52% to 10,384 units

ByQuantisnow·Wall Street's wire, on your screen.
NBRV· Nabriva Therapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBRV (Nabriva Therapeutics plc) and more on Quantisnow.